Endometriosis and nuclear receptors
Open accessThe DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index; 46 of the 107 sources its claims cite were checked for support.
Abstract
BACKGROUND: Endometriosis is recognized as a steroid-dependent disorder; however, the precise roles of nuclear receptors (NRs) in steroid responsiveness and other signaling pathways are not well understood. OBJECTIVE AND RATIONALE: Over the past several years, a number of paradigm-shifting breakthroughs have occurred in the area of NRs in endometriosis. We review and clarify new information regarding the mechanisms responsible for: (i) excessive estrogen biosynthesis, (ii) estrogen-dependent inflammation, (iii) defective differentiation due to progesterone resistance and (iv) enhanced survival due to deficient retinoid production and action in endometriosis. We emphasize the roles of the relevant NRs critical for these pathological processes in endometriosis. SEARCH METHODS: We conducted a comprehensive search using PubMed for human, animal and cellular studies published until 2018 in the following areas: endometriosis; the steroid and orphan NRs, estrogen receptors alpha (ESR1) and beta (ESR2), progesterone receptor (PGR), steroidogenic factor-1 (NR5A1) and chicken ovalbumin upstream promoter-transcription factor II (NR2F2); and retinoids. OUTCOMES: Four distinct abnormalities in the intracavitary endometrium and extra-uterine endometriotic tissue underlie endometriosis progression: dysregulated differentiation of endometrial mesenchymal cells, abnormal epigenetic marks, inflammation activated by excess estrogen and the development of progesterone resistance. Endometriotic stromal cells compose the bulk of the lesions and demonstrate widespread epigenetic abnormalities. Endometriotic stromal cells also display a wide range of abnormal NR expression. The orphan NRs NR5A1 and NR2F2 compete to regulate steroid-synthesizing genes in endometriotic stromal cells; NR5A1 dominance gives rise to excessive estrogen formation. Endometriotic stromal cells show an abnormally low ESR1:ESR2 ratio due to excessive levels of ESR2, which mediates an estrogen-driven inflammatory process and prostaglandin formation. These cells are also deficient in PGR, leading to progesterone resistance and defective retinoid synthesis. The pattern of NR expression, involving low ESR1 and PGR and high ESR2, is reminiscent of uterine leiomyoma stem cells. This led us to speculate that endometriotic stromal cells may display stem cell characteristics found in other uterine tissues. The biologic consequences of these abnormalities in endometriotic tissue include intense inflammation, defective differentiation and enhanced survival. WIDER IMPLICATIONS: Steroid- and other NR-related abnormalities exert genome-wide biologic effects via interaction with defective epigenetic programming and enhance inflammation in endometriotic stromal cells. New synthetic ligands, targeting PGR, retinoic acid receptors and ESR2, may offer novel treatment options.
Overview
CoChat Summary
TL;DR
This review synthesizes evidence that nuclear receptors—especially NR5A1, NR2F2, ESR1/ESR2, PGR, and retinoid receptors—drive endometriosis through excessive local estrogen synthesis, estrogen-dependent inflammation, progesterone resistance, and deficient retinoid action. It highlights epigenetic abnormalities in endometriotic stromal cells and stem-cell-like populations as central mechanisms and discusses emerging receptor-targeted therapies.
Key findings
- NR5A1 mRNA is ~12,000-fold higher in endometriosis than in eutopic endometrium; NR5A1 binds promoters of StAR, CYP11A1, HSD3B2, CYP17A1, and aromatase, and competes with NR2F2 to activate steroidogenic genes in endometriotic stromal cells.
- ESR2 RNA is 40- to 140-fold higher in stromal cells from ovarian endometriomas than in healthy eutopic endometrial stromal cells; the ESR2:ESR1 mRNA ratio reaches an ~800-fold difference, while ESR1 mRNA is ~7-fold lower.
- Progesterone resistance involves very low PGR-A and undetectable PGR-B in peritoneal endometriotic lesions, with PGR-B promoter hypermethylation and microRNA-mediated PGR downregulation (e.g., miR-194-3p, miR-196a, miR-29c).
- Retinoid deficiency in endometriotic stromal cells includes downregulated STRA6, deficient RBP1, higher CYP26B1, and a decreased CRABP2:FABP5 ratio, favoring FABP5/PPAR-β/δ-mediated survival and reduced HSD17B2-dependent estradiol inactivation.
Methods
- Comprehensive PubMed search for English-language human, animal, and cellular studies published until June 2018, using keywords including endometriosis, ESR1, ESR2, PGR, NR5A1, NR2F2, RAR, and endometrial stem cells.
- Narrative review and synthesis of the literature on nuclear receptors in endometriosis pathogenesis, progression, and therapeutic targeting; no formal meta-analysis or quantitative pooling is described.
Limitations
- The paper states that no germ-line or causative somatic mutations have been reported in endometriosis, that the relationship between DNMT expression and ESR2 promoter hypomethylation remains to be discovered, that long-term efficacy of SPRMs remains to be proven, and that future preclinical studies are required for ESR2-targeting agents.
- Evident from the text: this is a narrative review with a PubMed search limited to June 2018, relying heavily on animal and cell-culture models; it reports inconsistent polymorphism associations and does not perform a systematic risk-of-bias assessment or quantitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
37 Valid · 3 Not valid · 40 Not checked · 31 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“NR5A1 serves as a key downstream mediator of prostaglandin E 2 (PGE 2 ) action”
What the sources say
- Disputedcites Sirianni et al., 2009 matched to “Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells” (2009) sourceExperimental — accuracy not yet measured
The paper distinguishes SF-1 (NR5A1) from the PGE2-mediated pathway. Its introductory text attributes increased SF-1 transcription to insulin-like growth factor I signaling, while the Abstract identifies EP4, PKA and CREB—not SF-1—as mediators of PGE2 action. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“It was shown that cytokines such as colony-stimulating factor-1 secreted from macrophages increase the proliferation and invasion activity of endometriotic stem cells (Chan et al., 2017).”
What the sources say
- Disputedcites Chan et al., 2017 matched to “Co-culture with macrophages enhances the clonogenic and invasion activity of endometriotic stromal cells” (2017) sourceExperimental — accuracy not yet measured
The Results report that macrophage co-culture increased the clonogenicity and invasion of endometriotic stromal cells. But the Discussion explicitly says CSF-1 alone did not affect either activity; the factors responsible for the co-culture effect were not determined. The cited paper therefore does not support attributing the increase to macrophage-secreted CSF-1. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“When injected into subcutaneous tissue or the kidney capsule of NOD-SCID mouse, side population cells regenerate human endometrial stroma, glandular epithelium and endothelium (Cervello et al., 2010(Cervello et al., , 2011;;Miyazaki et al., 2012).”
What the sources say
- Partly supportedcites Cervello et al., 2010 matched to “Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells” (2010) sourceExperimental — accuracy not yet measured
The Results section (‘Reconstruction of human endometrial-like tissue from SP in NOD-SCID mice’; page unavailable) reports endometrial-like glands and stroma after subcutaneous injection of stromal side-population cells, but only in one animal. The Methods describe subcutaneous injection, not injection under the kidney capsule. The observed structure was vascularized, but the paper does not establish regeneration of human endothelium. (LLM, conf=0.88)
- Disputedcites Cervello et al., 2011 matched to “Reconstruction of endometrium from human endometrial side population cell lines” (2011) sourceExperimental — accuracy not yet measured
The Results section (page unavailable) supports reconstruction of human endometrial tissue beneath the kidney capsule, with human stromal and epithelial markers. But it explicitly reports that the human endothelial marker hCD31 was not detected and suggests the new blood vessels came from the mouse host, contrary to the claim that the cells regenerated human endothelium. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites Miyazaki et al., 2012 matched to “Stem cell-like differentiation potentials of endometrial side population cells as revealed by a newly developed in vivo endometrial stem cell assay” (2012) sourceExperimental — accuracy not yet measured
The Results (Histological and Immunohistochemical Analysis; page unavailable) report that endometrial side population cells contributed to reconstituted stromal, epithelial and endothelial lineages. But the Methods (Xenotransplantation and Hormonal Treatment; page unavailable) place the cells under the kidney capsule of NOG mice, not in subcutaneous tissue; the subcutaneous implants were hormone pellets. The assay also mixed the side population cells with other endometrial cells. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the endometriotic stromal cells, NR5A1 is essential for supporting high levels of proteins and enzymes that drive the serial conversion of cholesterol to estradiol”
What the sources say
- Partly supportedcites Attar et al., 2009 matched to “Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis” (2009) sourceExperimental — accuracy not yet measured
The Discussion (page not available) says endometriotic stromal cells contain the full enzymatic cascade for producing estradiol from cholesterol and identifies the PGE2–SF1 pathway as a key regulator. The gene-expression results also show high SF1 and steroidogenic-gene mRNA levels in endometriotic tissue. The paper does not establish that SF1 is essential for maintaining those levels; it describes SF1 as a possible key regulator and shows that its overexpression activates a promoter. (LLM, conf=0.83)
- Not matchedcites Bernardi et al., 2018
An author–year citation the paper’s reference list doesn’t settle. We don’t search these by name.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“RNA expression of ESR2 is 40-to 140-fold higher in stromal cells obtained from ovarian endometriomas compared to healthy eutopic endometrial stromal cells”
What the sources say
- Not checked — no full text of the sourcecites Smuc et al., 2007 matched to “Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis” (2007) source
- Not matchedcites Xue et al., 2007a
More than one paper fits this citation.
- Partly supportedcites Yang et al., 2015 matched to “Integrative analysis reveals regulatory programs in endometriosis” (2015) sourceExperimental — accuracy not yet measured
The Discussion reports that ESR2 expression was upregulated in endometriosis samples. It does not report a 40- to 140-fold increase or establish that comparison specifically for stromal cells from ovarian endometriomas versus healthy eutopic endometrial stromal cells. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims · 18 with their cited sources checked
Create a free account to see all 111 claims and every source verdict.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 18
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PR resistance in endometriotic cells results in CRABP2 deficiency, thereby favoring survival, development and persistence of endometriotic implants [15,16].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the follicular phase, estrogen acts on eutopic endometrium through the estrogen receptor (ER) to increase transcription and protein levels of the progesterone receptor (PR), especially the PR-B isoform.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in endometriotic implants, ERα is reduced but ERβ activity is upregulated, leading to complete loss of PR-B, which is then unable to induce 17β-HSD2.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In endometrial stromal cells, progesterone increases formation of RA, which triggers expression of 17β-HSD2 in epithelial cells.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“As estrogens play a crucial role not only in survival of endometriotic implants, but also in coordinated vasculogenesis and neurogenesis [110] by different pathways involving ER signaling [15,16], it is logical to consider lowering estrogen levels as a therapeutic approach.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Retinoic acid signaling and function in the endometrium
“peroxisome proliferator-activated receptor beta/delta (PPAR-β/δ)”
§ Discussion
“PPARβ/δ, peroxisome proliferator-activated receptors beta/gamma;”
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I., & Julius, D. (2000) · Science · doi:10.1126/science.288.5464.306 · Cited by 3,544
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269 · cited 1×
“The nuclear estrogen receptor subtypes are ESR1 and ESR2, which are encoded by different genes but have 96% similarity in their DNA binding domains (Mosselman et al., 1996).”
BackgroundESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211 · cited 1×
“and antagonists, oral or injectable progestins and aromatase inhibitors (Dunselman et al., 2014).”
BackgroundEndometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationLuo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631 · cited 2×
“NR5A1 plays a critical role in regulating steroidogenic pathways in the adrenal gland, testis and ovary (Luo et al., 1994; Hanley et al., 2000).”
BackgroundKastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191 · cited 1×
“In various cancer types, methylation of CpG islands in the promoter region of the ESR1 gene is associated with gene silencing (Issa et al., 1994; Ottaviano et al., 1994).”
Background(1927) · PubMed Central · Cited by 1,008
(1984) · PubMed · Cited by 997
Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., & McDonnell, D. P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264658 · Cited by 760
Burney, R. O., Talbi, S., Hamilton, A. E., Vo, K. C., Nyegaard, M., Nezhat, C. R., Lessey, B. A., & Giudice, L. C. (2007) · Endocrinology · doi:10.1210/en.2006-1692 · Cited by 735 · cited 1×
“Further comparisons at various points during the menstrual cycle show dysregulated gene expression in the early secretory phase, with increased survival and mitotic activity (Burney et al., 2007).”
BackgroundSubgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., & Conneely, O. M. (2000) · Science · doi:10.1126/science.289.5485.1751 · Cited by 704
Bulun, S. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1209993 · Cited by 703 · cited 4×
“(B) In leiomyoma smooth muscle cells, a homodimer of PGRs liganded with progesterone (P) bind to a specific progesterone response element (PRE) and assemble a specific complex including a co-activator to start transcription of progesterone target genes such as BCL2 (Bulun, 2013).”
BackgroundInfluentialSelf-citationKao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A., & Giudice, L. C. (2003) · Endocrinology · doi:10.1210/en.2003-0043 · Cited by 696
Overview of nomenclature of nuclear receptors
Germain, P., Staels, B., Dacquet, C., Spedding, M., & Laudet, V. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.2 · Cited by 688 · cited 1×
“tion of hormone-inducible genes (Germain et al., 2006) (Fig.”
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
Clonogenicity of Human Endometrial Epithelial and Stromal Cells1
Chan, R. W. S., Schwab, K. E., & Gargett, C. E. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.024109 · Cited by 653
Cancer-associated mutations in endometriosis without cancer
Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noë, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614814 · Cited by 628 · cited 1×
“ponent of ovarian endometriomas or deep-infiltrating endometriosis, stromal cells consistently lack any somatic mutations (Anglesio et al., 2017).”
BackgroundEndocrine regulation of menstruation
Jabbour, H. N., Kelly, R. W., Fraser, H. M., & Critchley, H. O. D. (2006) · Endocrine Reviews · doi:10.1210/er.2004-0021 · Cited by 588 · cited 1×
“The endometrium undergoes cyclical regeneration in response to the steroid hormones estradiol and progesterone (Jabbour et al., 2006).”
BackgroundEndometrial stem/progenitor cells: the first 10 years
Gargett, C. E., Schwab, K. E., & Deane, J. A. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv051 · Cited by 561
Ottaviano, Y. L., Issa, J. J., Parl, F. F., Smith, H. S., Baylin, S. B., & Davidson, N. E. (1994) · PubMed · Cited by 559
Consensus on current management of endometriosis
Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J., & Conneely, O. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732707100 · Cited by 547
Schwab, K. E., & Gargett, C. E. (2007) · Human Reproduction · doi:10.1093/humrep/dem265 · Cited by 545
Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.6 · Cited by 531
Self-citationVimentin is secreted by activated macrophages
Mor-Vaknin, N., Punturieri, A., Sitwala, K., & Markovitz, D. M. (2003) · Nature Cell Biology · doi:10.1038/ncb898 · Cited by 522
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Self-citationEndometrial cells derived from donor stem cells in bone marrow transplant recipients
Taylor, H. S. (2004) · JAMA · doi:10.1001/jama.292.1.81 · Cited by 510
Estrogen receptor (ER) β, a modulator of ERα in the uterus
Weihua, Z., Saji, S., Mäkinen, S., Cheng, G., Jensen, E. V., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5936 · Cited by 507
Tan, N.-S., Shaw, N. S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B., Wahli, W., & Noy, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5114-5127.2002 · Cited by 499
A side order of stem cells: the SP phenotype
Challen, G. A., & Little, M. H. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0116 · Cited by 475
Heritable aspects of endometriosis
Simpson, J. L., Elias, S., Malinak, L. R., & Buttram, V. C. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90917-5 · Cited by 468
Contribution of Bone Marrow-Derived Stem Cells to Endometrium and Endometriosis
Du, H., & Taylor, H. S. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0828 · Cited by 449
Progesterone resistance in endometriosis: link to failure to metabolize estradiol.
Bulun, S. E., Cheng, Y.-H., Yin, P., Imir, G., Utsunomiya, H., Attar, E., Innes, J., & Julie Kim, J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.041 · Cited by 397
Self-citationHan, S. J., Jung, S. Y., Wu, S.-P., Hawkins, S. M., Park, M. J., Kyo, S., Qin, J., Lydon, J. P., Tsai, S. Y., Tsai, M.-J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.034 · Cited by 380
Adult stem cells in the endometrium
Gargett, C. E., & Masuda, H. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq061 · Cited by 361 · cited 5×
“Comparison of post-menopausal and premenopausal endometrial tissues revealed eMSCs with similar self-renewal capacity and expression of SUSD2 (Ulrich et al., 2014).”
BackgroundInfluentialMicroRNA-regulated pathways associated with endometriosis
Ohlsson Teague, E. M. C., Van der Hoek, K. H., Van der Hoek, M. B., Perry, N., Wagaarachchi, P., Robertson, S. A., Print, C. G., & Hull, L. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0387 · Cited by 357
Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1
Xue, Q., Lin, Z., Cheng, Y.-H., Huang, C.-C., Marsh, E., Yin, P., Milad, M. P., Confino, E., Reierstad, S., Innes, J., et al. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.061804 · Cited by 346
Self-citationSantamaria, X., Cabanillas, S., Cervelló, I., Arbona, C., Raga, F., Ferro, J., Palmero, J., Remohí, J., Pellicer, A., & Simón, C. (2016) · Human Reproduction · doi:10.1093/humrep/dew042 · Cited by 342
Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H. (2001) · Nature Medicine · doi:10.1038/89050 · Cited by 340
Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis
Wu, Y., Strawn, E., Basir, Z., Halverson, G., & Guo, S.-W. (2006) · Epigenetics · doi:10.4161/epi.1.2.2766 · Cited by 321
Role of Estrogen Receptor-β in Endometriosis
Bulun, S., Monsavais, D., Pavone, M., Dyson, M., Xue, Q., Attar, E., Tokunaga, H., & Su, E. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1299596 · Cited by 321 · cited 1×
“…PGR isoforms increase throughout the proliferative phase and peak before ovulation under the influence of increasing estrogen levels; in endometriosis, PGR levels remain very low to undetectable, possibly due to an abnormally low ESR1: ESR2 ratio in endometriotic stromal cells (Bulun et al., 2012).”
BackgroundSelf-citationChabbert-Buffet, N., Meduri, G., Bouchard, P., & Spitz, I. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi002 · Cited by 310
Masuda, H., Matsuzaki, Y., Hiratsu, E., Ono, M., Nagashima, T., Kajitani, T., Arase, T., Oda, H., Uchida, H., Asada, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010387 · Cited by 303 · cited 2×
“…multipotent, clonogenic stem cells that can give rise to mesodermal lineages in vitro. eMSCs were first isolated from the endometrium as CD146(+)PDGFRB(+) dual positive cells and later by a novel single cell surface marker, sushi domain containing-2 (SUSD2) (Gargett and Masuda, 2010).”
BackgroundProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Self-citationA novel marker of human endometrial mesenchymal stem-like cells
Masuda, H., Anwar, S. S., Bühring, H.-J., Rao, J. R., & Gargett, C. E. (2012) · Cell Transplantation · doi:10.3727/096368911x637362 · Cited by 294 · cited 1×
“Similar to the side population, eMSCs are located in the perivascular region and they are present in both functionalis and basalis layers (Schwab and Gargett, 2007; Masuda et al., 2012).”
BackgroundTreatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Self-citationMote, P. A., Balleine, R. L., McGowan, E. M., & Clarke, C. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5928 · Cited by 270
Schwab, K. E., Chan, R. W. S., & Gargett, C. E. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.02.056 · Cited by 249
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
Shang, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1879 · Cited by 246
Ovulation suppression for endometriosis
Hughes, E., Fedorkow, D., Collins, J., & Vandekerckhove, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000155 · Cited by 245
Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis
Bulun, S., Cheng, Y.-H., Pavone, M., Xue, Q., Attar, E., Trukhacheva, E., Tokunaga, H., Utsunomiya, H., Yin, P., Luo, X., et al. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242991 · Cited by 243 · cited 1×
“This emphasizes the paramount importance of estrogen to the pathogenesis of endometriosis: estrogen promotes endometriotic cell survival, inflammation and lesion progression (Bulun et al., 2010; Monsivais et al., 2016).”
BackgroundSelf-citationShaw, N., Elholm, M., & Noy, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300368200 · Cited by 243 · cited 1×
“Alternatively, retinoic acid can activate transcription to promote cell survival through an orphan NR, peroxisome proliferator-activated receptor beta/delta (PPAR-β/δ) (Shaw et al., 2003).”
BackgroundSoysal, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh035 · Cited by 227 · cited 1×
“Inhibition of local estrogen production via aromatase inhibitors may further improve symptom relief (Takayama et al., 1998; Soysal et al., 2004).”
BackgroundXue, Q., Lin, Z., Yin, P., Milad, M. P., Cheng, Y.-H., Confino, E., Reierstad, S., & Bulun, S. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0494 · Cited by 219
Self-citationTreatment of endometriosis with the antiprogesterone mifepristone (RU486)
Michael Kettel, L., Murphy, A. A., Morales, A. J., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58022-4 · Cited by 216
Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids
Donnez, J., Hudecek, R., Donnez, O., Matule, D., Arhendt, H.-J., Zatik, J., Kasilovskiene, Z., Dumitrascu, M. C., Fernandez, H., Barlow, D. H., et al. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.10.038 · Cited by 216 · cited 1×
“These agents also reduce abnormal uterine bleeding that is observed with progestin treatment (Donnez et al., 2015).”
BackgroundZeitoun, K., Takayama, K., Michael, M. D., & Bulun, S. E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0229 · Cited by 216 · cited 2×
“orphan NRs, steroidogenic factor-1 (NR5A1) and chicken ovalbumin upstream promoter-transcription factor II (NR2F2) also play critical roles in regulating local estrogen concentrations in endometriosis (Zeitoun et al., 1999; Attar et al., 2009; Bernardi et al., 2018).”
BackgroundSelf-citationCasey, M. L., MacDonald, P. C., & Andersson, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117569 · Cited by 212
Dyson, M. T., Roqueiro, D., Monsivais, D., Ercan, C. M., Pavone, M. E., Brooks, D. C., Kakinuma, T., Ono, M., Jafari, N., Dai, Y., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004158 · Cited by 211 · cited 2×
“Genome-wide methylation studies show that functionally important genes in endometriosis are differentially expressed in accordance with their aberrant methylation status (Dyson et al., 2014; Yotova et al., 2017).”
BackgroundSelf-citationThe search for genes contributing to endometriosis risk
Montgomery, G. W., Nyholt, D. R., Zhao, Z. Z., Treloar, S. A., Painter, J. N., Missmer, S. A., Kennedy, S. H., & Zondervan, K. T. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn016 · Cited by 211
Critchley, H. O. D., Brenner, R. M., Henderson, T. A., Williams, K., Nayak, N. R., Slayden, O. D., Millar, M. R., & Saunders, P. T. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7317 · Cited by 210
Attar, E., Tokunaga, H., Imir, G., Yilmaz, M. B., Redwine, D., Putman, M., Gurates, B., Attar, R., Yaegashi, N., Hales, D. B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1180 · Cited by 207 · cited 4×
“orphan NRs, steroidogenic factor-1 (NR5A1) and chicken ovalbumin upstream promoter-transcription factor II (NR2F2) also play critical roles in regulating local estrogen concentrations in endometriosis (Zeitoun et al., 1999; Attar et al., 2009; Bernardi et al., 2018).”
BackgroundInfluentialSelf-citationVegeto, E. (1993) · Molecular Endocrinology · doi:10.1210/me.7.10.1244 · Cited by 205
COUP-TFII Mediates Progesterone Regulation of Uterine Implantation by Controlling ER Activity
Kurihara, I., Lee, D.-K., Petit, F. G., Jeong, J., Lee, K., Lydon, J. P., DeMayo, F. J., Tsai, M.-J., & Tsai, S. Y. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030102 · Cited by 202
Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis
Greaves, E., Temp, J., Esnal-Zufiurre, A., Mechsner, S., Horne, A. W., & Saunders, P. T. K. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.04.012 · Cited by 201 · cited 2×
“ESR2 signaling integrates inflammatory and pain pathways; macrophage infiltration of endometriosis increases in response to estradiol (Greaves et al., 2015).”
BackgroundProgesterone: the ultimate endometrial tumor suppressor
Yang, S., Thiel, K. W., & Leslie, K. K. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.01.005 · Cited by 194
Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis1
Attia, G. R., Zeitoun, K., Edwards, D., Johns, A., Carr, B. R., & Bulun, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6739 · Cited by 193
Self-citationCervelló, I., Gil-Sanchis, C., Mas, A., Delgado-Rosas, F., Martínez-Conejero, J. A., Galán, A., Martínez-Romero, A., Martínez, S., Navarro, I., Ferro, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010964 · Cited by 187
Reconstruction of endometrium from human endometrial side population cell lines
Cervelló, I., Mas, A., Gil-Sanchis, C., Peris, L., Faus, A., Saunders, P. T. K., Critchley, H. O. D., & Simón, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021221 · Cited by 178
Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis
Vercellini, P., Eskenazi, B., Consonni, D., Somigliana, E., Parazzini, F., Abbiati, A., & Fedele, L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq042 · Cited by 176
New developments in the medical treatment of endometriosis
Bedaiwy, M. A., Alfaraj, S., Yong, P., & Casper, R. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.025 · Cited by 176
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Zhao, Y., Gong, P., Chen, Y., Nwachukwu, J. C., Srinivasan, S., Ko, C., Bagchi, M. K., Taylor, R. N., Korach, K. S., Nettles, K. W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010626 · Cited by 170 · cited 2×
“results in murine models and should also be considered as potential therapeutics (Zhao et al., 2015).”
BackgroundBrandenberger, A. W. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.7.651 · Cited by 165 · cited 1×
“Several groups have reported significantly lower levels of ESR1 both in endometriomas and cultured endometriotic stromal cells obtained from cyst walls of ovarian disease (Brandenberger et al., 1999; Fujimoto et al., 1999; Smuc et al., 2007).”
BackgroundFiligheddu, N., Gregnanin, I., Porporato, P. E., Surico, D., Perego, B., Galli, L., Patrignani, C., Graziani, A., & Surico, N. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/369549 · Cited by 162
Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis
Cousins, F. L., O, D. F., & Gargett, C. E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.011 · Cited by 158
Lin, B. C., Suzawa, M., Blind, R. D., Tobias, S. C., Bulun, S. E., Scanlan, T. S., & Ingraham, H. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1622 · Cited by 157 · cited 1×
“As an example of a post-translational regulatory mechanism, direct phosphorylation of NR5A1, via selective stimulation of the membranebound estrogen receptor GPR30, increases NR5A1 transcriptional activity, leading to induction of aromatase expression in endometriotic stromal cells (Lin et al., 2009).”
BackgroundSelf-citationBarragan, F., Irwin, J. C., Balayan, S., Erikson, D. W., Chen, J. C., Houshdaran, S., Piltonen, T. T., Spitzer, T. L. B., George, A., Rabban, J. T., et al. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.115.136010 · Cited by 152
Kurita, T., Lee, K.-J., Cooke, P. S., Lydon, J. P., & Cunha, G. R. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.4.831 · Cited by 150
Han, S. J., Hawkins, S. M., Begum, K., Jung, S. Y., Kovanci, E., Qin, J., Lydon, J. P., DeMayo, F. J., & O'Malley, B. W. (2012) · Nature Medicine · doi:10.1038/nm.2826 · Cited by 149
Trukhacheva, E., Lin, Z., Reierstad, S., Cheng, Y.-H., Milad, M., & Bulun, S. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1466 · Cited by 143
Self-citationRole of stem cells in human uterine leiomyoma growth
Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., Druschitz, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036935 · Cited by 141 · cited 1×
“For the stimulation of clonal expansion and growth of leiomyoma, sex steroids and steroid hormone receptors are necessary; yet, leiomyoma stem cells express barely detectable levels of ESR1 or PGR (Mas et al., 2012; Ono et al., 2012).”
BackgroundSelf-citationLESSEY, B. A., SUE ALEXANDER, P., & HORWITZ, K. B. (1983) · Endocrinology · doi:10.1210/endo-112-4-1267 · Cited by 141 · cited 1×
“PGR-A is a 94 kDa protein, whereas PGR-B is 114 kDa protein with 164 additional amino acids at its Nterminal (Lessey et al., 1983; Alexander et al., 1989).”
BackgroundStratton, P., Sinaii, N., Segars, J., Koziol, D., Wesley, R., Zimmer, C., Winkel, C., & Nieman, L. K. (2008) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000297307.35024.b5 · Cited by 140
Ikoma, T., Kyo, S., Maida, Y., Ozaki, S., Takakura, M., Nakao, S., & Inoue, M. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.07.026 · Cited by 137
MicroRNA signature and regulatory functions in the endometrium during normal and disease states
Pan, Q., & Chegini, N. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-0028-1096128 · Cited by 134
Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis
Matsuzaki, S., Murakami, T., Uehara, S., Canis, M., Sasano, H., & Okamura, K. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01783-6 · Cited by 133 · cited 1×
“While ESR1 and ESR2 are both present in the endometrium, ESR1 expression dominates, and estrogen-dependent proliferation is mediated mainly through ESR1 (Matsuzaki et al., 2001; Shang, 2006).”
BackgroundDistinct Regulation of Cyclooxygenase-2 by Interleukin-1β in Normal and Endometriotic Stromal Cells
Wu, M.-H., Wang, C.-A., Lin, C.-C., Chen, L.-C., Chang, W.-C., & Tsai, S.-J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1612 · Cited by 127
Du, H., Naqvi, H., & Taylor, H. S. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0193 · Cited by 126
Šmuc, T., Pucelj, M. R., Šinkovec, J., Husen, B., Thole, H., & Rižner, T. L. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601152219 · Cited by 124
Donato, L. J., & Noy, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1177 · Cited by 123 · cited 1×
“Transcriptional activation through RARs may trigger differentiation, cell-cycle arrest and apoptosis (Altucci et al., 2001; Kitareewan et al., 2002; Donato and Noy, 2005).”
BackgroundExpression of oestrogen receptor-alpha and -beta in ovarian endometriomata
Fujimoto, J. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.8.742 · Cited by 123
Ovulation suppression for endometriosis for women with subfertility
Hughes, E., Brown, J., Collins, J. J., Farquhar, C., Fedorkow, D. M., & Vanderkerchove, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000155.pub2 · Cited by 121
PROGINS receptor gene polymorphism is associated with endometriosis
Wieser, F., Schneeberger, C., Tong, D., Tempfer, C., Huber, J. C., & Wenzl, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02984-3 · Cited by 120 · cited 1×
“Associations of PGR gene polymorphisms with endometriosis have been reported but results are inconsistent (Wieser et al., 2002; Lattuada et al., 2004; De Carvalho et al., 2007; van Kaam et al., 2007).”
ResultTamura, M., Sebastian, S., Yang, S., Gurates, B., Fang, Z., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8594 · Cited by 117
Self-citationKitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C. H., Nemeth, M. J., Golub, T. R., Freemantle, S. J., & Dmitrovsky, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052011299 · Cited by 117 · cited 1×
“Transcriptional activation through RARs may trigger differentiation, cell-cycle arrest and apoptosis (Altucci et al., 2001; Kitareewan et al., 2002; Donato and Noy, 2005).”
BackgroundSun, H. S., Hsiao, K.-Y., Hsu, C.-C., Wu, M.-H., & Tsai, S.-J. (2003) · Endocrinology · doi:10.1210/en.2003-0289 · Cited by 114 · cited 1×
“Estradiol- and cytokine-induced stimulation of cyclooxygenase-2 (COX-2) leads to overproduction of PGE2, which in turn binds to its receptor on endometriotic stromal cells and elevates intracellular levels of cAMP (Noble et al., 1997; Tamura et al., 2002, 2004; Sun et al., 2003; Wu et al., 2005).”
BackgroundCritchley, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1370 · Cited by 114
Kulak, J., Fischer, C., Komm, B., & Taylor, H. S. (2011) · Endocrinology · doi:10.1210/en.2010-1010 · Cited by 112
Alexander, I. E., Clarke, C. L., Shine, J., & Sutherland, R. L. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-9-1377 · Cited by 109
Estrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107 · cited 1×
“The biologically active estrogen estradiol acts via nuclear estrogen receptors to regulate growth of the endometrial tissue (Huhtinen et al., 2012).”
BackgroundWang, X., Allen, C., & Ballow, M. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9068-5 · Cited by 107 · cited 2×
“In an immunocompetent mouse model, retinoic acid was shown to inhibit the development of peritoneal endometriotic implants while reducing IL-6 and monocyte chemoattractant protein 1 levels and increasing macrophage differentiation (Wieser et al., 2012).”
BackgroundTamura, M., Deb, S., Sebastian, S., Okamura, K., & Bulun, S. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.076 · Cited by 107 · cited 2×
“Endothelial cells in the human endometrium express ESR2 but not ESR1 (Critchley et al., 2001; Tamura et al., 2004).”
BackgroundSelf-citationMas, A., Cervelló, I., Gil-Sanchis, C., Faus, A., Ferro, J., Pellicer, A., & Simón, C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.044 · Cited by 104 · cited 1×
“For the stimulation of clonal expansion and growth of leiomyoma, sex steroids and steroid hormone receptors are necessary; yet, leiomyoma stem cells express barely detectable levels of ESR1 or PGR (Mas et al., 2012; Ono et al., 2012).”
BackgroundDNA methylation in endometriosis (Review)
KOUKOURA, O., SIFAKIS, S., & SPANDIDOS, D. A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4925 · Cited by 103
Grandien, K. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03716-0 · Cited by 100 · cited 1×
“ESR2 binds to alternatively used promoter regions of the ESR1 in the presence of estradiol and suppresses its expression (Grandien, 1996; Donaghue et al., 1999; Trukhacheva et al., 2009).”
BackgroundCervelló, I., Gil-Sanchis, C., Mas, A., Faus, A., Sanz, J., Moscardó, F., Higueras, G., Sanz, M. A., Pellicer, A., & Simón, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030260 · Cited by 99 · cited 1×
“Later studies suggested that BMDSCs may differentiate into stroma or epithelium but do not contribute to the endometrial progenitor population (Cervello et al., 2012).”
BackgroundThe important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Rižner, T. L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00030 · Cited by 98
Chan, R. W. S., Ng, E. H. Y., & Yeung, W. S. B. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.025 · Cited by 98 · cited 10×
“Comparison of post-menopausal and premenopausal endometrial tissues revealed eMSCs with similar self-renewal capacity and expression of SUSD2 (Ulrich et al., 2014).”
BackgroundInfluentialEndometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications
Monteiro, J. B., Colón-Díaz, M., García, M., Gutierrez, S., Colón, M., Seto, E., Laboy, J., & Flores, I. (2014) · Reproductive Sciences · doi:10.1177/1933719113497267 · Cited by 98
Lin, Z., Reierstad, S., Huang, C.-C., & Bulun, S. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3696 · Cited by 93
Self-citationMesenchymal stem/stromal cells in post-menopausal endometrium
Ulrich, D., Tan, K. S., Deane, J., Schwab, K., Cheong, A., Rosamilia, A., & Gargett, C. E. (2014) · Human Reproduction · doi:10.1093/humrep/deu159 · Cited by 91
Monsivais, D., Dyson, M. T., Yin, P., Coon, J. S., Navarro, A., Feng, G., Malpani, S. S., Ono, M., Ercan, C. M., Wei, J. J., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1421 · Cited by 91 · cited 5×
“Estrogen receptors alpha and beta (ESR1 and ESR2) and progesterone receptor (PGR) are the key steroid receptors involved in the pathophysiology of endometriosis (Attia et al., 2000; Monsivais et al., 2014).”
BackgroundInfluentialSelf-citationZhou, M., Fu, J., Xiao, L., Yang, S., Song, Y., Zhang, X., Feng, X., Sun, H., Xu, W., & Huang, W. (2016) · Human Reproduction · doi:10.1093/humrep/dew223 · Cited by 91
Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue
Fang, Z., Yang, S., Gurates, B., Tamura, M., Simpson, E., Evans, D., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8683 · Cited by 91 · cited 1×
“The disruption of menses usually provides relief from endometriosis symptoms (Fang et al., 2002; Vercellini et al., 2011).”
BackgroundSelf-citationElevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis
Greaves, E., Grieve, K., Horne, A. W., & Saunders, P. T. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2282 · Cited by 89
Mote, P. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2963 · Cited by 89
Joshi, N. R., Miyadahira, E. H., Afshar, Y., Jeong, J.-W., Young, S. L., Lessey, B. A., Serafini, P. C., & Fazleabas, A. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2076 · Cited by 87
Yang, S., Fang, Z., Gurates, B., Tamura, M., Miller, J., Ferrer, K., & Bulun, S. E. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0742 · Cited by 84
Self-citationYotova, I., Hsu, E., Do, C., Gaba, A., Sczabolcs, M., Dekan, S., Kenner, L., Wenzl, R., & Tycko, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170859 · Cited by 81
Wu, Y., Starzinski‐Powitz, A., & Guo, S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.008 · Cited by 79
Yang, S., Fang, Z., Suzuki, T., Sasano, H., Zhou, J., Gurates, B., Tamura, M., Ferrer, K., & Bulun, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8486 · Cited by 77
Self-citationAfshar, Y., Hastings, J., Roqueiro, D., Jeong, J.-W., Giudice, L. C., & Fazleabas, A. T. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.104497 · Cited by 77 · cited 1×
“lesions but also in the eutopic endometrium (Afshar et al., 2013).”
BackgroundMiyazaki, K., Maruyama, T., Masuda, H., Yamasaki, A., Uchida, S., Oda, H., Uchida, H., & Yoshimura, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050749 · Cited by 76
Stovall, D. W., Bowser, L. M., Archer, D. F., & Guzick, D. S. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81468-9 · Cited by 75
Altered retinoid uptake and action contributes to cell survival in endometriosis
Pavone, M. E., Reierstad, S., Sun, H., Milad, M., Bulun, S. E., & Cheng, Y.-H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0459 · Cited by 74 · cited 4×
“FABP5 dominancy promotes the shuttling of retinoic acid to PPAR-β/δ, which promotes cell survival and impairs apoptosis (Pavone et al., 2010).”
BackgroundInfluentialSelf-citationPei, T., Liu, C., Liu, T., Xiao, L., Luo, B., Tan, J., Li, X., Zhou, G., Duan, C., & Huang, W. (2018) · Endocrinology · doi:10.1210/en.2018-00374 · Cited by 73
Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis
Utsunomiya, H., Cheng, Y.-H., Lin, Z., Reierstad, S., Yin, P., Attar, E., Xue, Q., Imir, G., Thung, S., Trukhacheva, E., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2006-0302 · Cited by 72
Self-citationSelective Promoter Usage of the Human Estrogen Receptor-α Gene and Its Regulation by Estrogen
Donaghue, C., Westley, B. R., & May, F. E. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.11.0366 · Cited by 72
Occult microscopic endometriosis: undetectable by laparoscopy in normal peritoneum
Khan, K. N., Fujishita, A., Kitajima, M., Hiraki, K., Nakashima, M., & Masuzaki, H. (2014) · Human Reproduction · doi:10.1093/humrep/det438 · Cited by 72 · cited 1×
“Even macroscopically invisible implants may lead to persistent pain yet respond to suppression of ovulation (Khan et al., 2014).”
BackgroundCheng, Y.-H., Yin, P., Xue, Q., Yilmaz, B., Dawson, M. I., & Bulun, S. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1536 · Cited by 71 · cited 2×
“Progesterone via PGR induces retinoic acid production in endometrial stromal cells, which then acts on epithelial cells to induce HSD17B2 expression (Casey et al., 1994; Cheng et al., 2008).”
BackgroundSelf-citationInsights into assessing the genetics of endometriosis
Rahmioglu, N., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0016-5 · Cited by 71 · cited 1×
“dence that endometriosis may be an inheritable disease, no germ-line or causative somatic mutations have been reported to date (Montgomery et al., 2008; Rahmioglu et al., 2012).”
BackgroundGenome-wide DNA methylation profiling in cultured eutopic and ectopic endometrial stromal cells
Yamagata, Y., Nishino, K., Takaki, E., Sato, S., Maekawa, R., Nakai, A., & Sugino, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083612 · Cited by 70 · cited 1×
“Hypomethylation of a critical CpG island at the promoter region of NR5A1 is accompanied by remarkably high NR5A1 mRNA expression in stromal cells collected from ovarian endometriomas (Xue et al., 2007b; Yamagata et al., 2014).”
Backgroundvan Kaam, K. J. A. F., Delvoux, B., Romano, A., D’Hooghe, T., Dunselman, G. A. J., & Groothuis, P. G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.031 · Cited by 64
Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?
Lattuada, D., Somigliana, E., Viganò, P., Candiani, M., Pardi, G., & Di Blasio, A. M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02076.x · Cited by 64
Hsiao, K.-Y., Wu, M.-H., Chang, N., Yang, S.-H., Wu, C.-W., Sun, H. S., & Tsai, S.-J. (2015) · Molecular Human Reproduction · doi:10.1093/molehr/gav054 · Cited by 64
FKBP4 is regulated by HOXA10 during decidualization and in endometriosis
Yang, H., Zhou, Y., Edelshain, B., Schatz, F., Lockwood, C. J., & Taylor, H. S. (2012) · Reproduction · doi:10.1530/rep-11-0438 · Cited by 63
Monsivais, D., Dyson, M. T., Yin, P., Navarro, A., Coon, J. S., Pavone, M. E., & Bulun, S. E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.01.012 · Cited by 62 · cited 2×
“Another estradiol-regulated ESR2 target gene, serum and glucocorticoid-regulated kinase (SGK1), is also induced by PGE2 and contributes to survival of endometriotic cells via inhibition of apoptosis (Monsivais et al., 2016).”
BackgroundSelf-citationProgesterone receptor modulators for endometriosis
Fu, J., Song, H., Zhou, M., Zhu, H., Wang, Y., Chen, H., & Huang, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009881.pub2 · Cited by 61
Yao, Z., Shen, X., Capodanno, I., Donnelly, M., Fenyk-Melody, J., Hausamann, J., Nunes, C., Strauss, J., & Vakerich, K. (2005) · Journal of Investigative Surgery · doi:10.1080/08941930591004412 · Cited by 60
COUP-TFII Regulates Human Endometrial Stromal Genes Involved in Inflammation
Li, X., Large, M. J., Creighton, C. J., Lanz, R. B., Jeong, J., Young, S. L., Lessey, B. A., Palomino, W. A., Tsai, S. Y., & DeMayo, F. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1191 · Cited by 60
Comparison of the effects of raloxifene and anastrozole on experimental endometriosis
Altintas, D., Kokcu, A., Kandemir, B., Tosun, M., & Cetinkaya, M. B. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.004 · Cited by 57
Shen, L., Yang, S., Huang, W., Xu, W., Wang, Q., Song, Y., & Liu, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3010 · Cited by 57 · cited 1×
“miR23a and miR23b levels are lower in endometriosis and in the eutopic endometrium of women with endometriosis, and they inversely correlate with NR5A1 levels, yet NR5A1 is not a direct target of miR23a and miR23b (Shen et al., 2013).”
BackgroundWieser, F., Wu, J., Shen, Z., Taylor, R. N., & Sidell, N. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.004 · Cited by 56
Bone marrow stem cells do not contribute to endometrial cell lineages in chimeric mouse models
Ong, Y. R., Cousins, F. L., Yang, X., Mushafi, A. A. A. A., Breault, D. T., Gargett, C. E., & Deane, J. A. (2018) · Stem Cells · doi:10.1002/stem.2706 · Cited by 56
Pavone, M. E., Dyson, M., Reirstad, S., Pearson, E., Ishikawa, H., Cheng, Y. H., & Bulun, S. E. (2011) · Human Reproduction · doi:10.1093/humrep/der172 · Cited by 56
Self-citationNaqvi, H., Sakr, S., Presti, T., Krikun, G., Komm, B., & Taylor, H. S. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.114165 · Cited by 54 · cited 1×
“Raloxifene and bazedoxifene both result in lesion regression and inhibition of proliferation in murine models (Yao et al., 2005; Kulak et al., 2011; Naqvi et al., 2014).”
BackgroundThe evolution of progesterone receptor ligands
Madauss, K. P., Stewart, E. L., & Williams, S. P. (2007) · Medicinal Research Reviews · doi:10.1002/med.20083 · Cited by 53
Lin, S.-C., Li, Y.-H., Wu, M.-H., Chang, Y.-F., Lee, D.-K., Tsai, S. Y., Tsai, M.-J., & Tsai, S.-J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3717 · Cited by 52
Steroidogenic factor 1 (SF-1) is essential for ovarian development and function
Hanley, N. A., Ikeda, Y., Luo, X., & Parker, K. L. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00237-3 · Cited by 51
van Kaam, K. J. A. F., Romano, A., Schouten, J. P., Dunselman, G. A. J., & Groothuis, P. G. (2006) · Human Reproduction · doi:10.1093/humrep/del325 · Cited by 51
Retinoic Acid Biosynthesis Is Impaired in Human and Murine Endometriosis1
Pierzchalski, K., Taylor, R. N., Nezhat, C., Jones, J. W., Napoli, J. L., Yang, G., Kane, M. A., & Sidell, N. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.119677 · Cited by 50
Xue, Q., Zhou, Y. F., Zhu, S. N., & Bulun, S. E. (2011) · Reproductive Sciences · doi:10.1177/1933719111404614 · Cited by 50
Self-citationReply: Consensus on current management of endometriosis
JOHNSON, N. P., & Hummelshøj, L. (2013) · Human Reproduction · doi:10.1093/humrep/det347 · Cited by 48
Chan, R. W. S., Lee, C., Ng, E. H. Y., & Yeung, W. S. B. (2017) · Cell Proliferation · doi:10.1111/cpr.12330 · Cited by 45
Laparoscopic Management of Patients with Endometriosis and Chronic Pelvic Pain
MILINGOS, S., PROTOPAPAS, A., DRAKAKIS, P., LIAPI, A., LOUTRADIS, D., KALLIPOLITIS, G., MILINGOS, D., & MICHALAS, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.030 · Cited by 45
Xue, Q., Xu, Y., Yang, H., Zhang, L., Shang, J., Zeng, C., Yin, P., & Bulun, S. E. (2014) · Reproductive Sciences · doi:10.1177/1933719113497283 · Cited by 45
Self-citationde Carvalho, C. V., Nogueira-de-Souza, N. C., Massad Costa, A. M., Baracat, E. C., Girão, M. J. B. C., D'amora, P., Schor, E., & Da Silva, I. D. C. G. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601024707 · Cited by 44
Liang, B., Wu, L., Xu, H., Cheung, C. W., Fung, W. Y., Wong, S. W., & Wang, C. C. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0347-9 · Cited by 41 · cited 1×
“UPA decreases lesion size, attenuates cell proliferation, and induces apoptosis in murine endometriosis models (Huniadi et al., 2013; Liang et al., 2018).”
BackgroundSirianni, R., Chimento, A., De Luca, A., Zolea, F., Carpino, A., Rago, V., Maggiolini, M., Andò, S., & Pezzi, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041020 · Cited by 41 · cited 1×
“NR5A1 serves as a key downstream mediator of prostaglandin E2 (PGE2) action (Sirianni et al., 2009).”
BackgroundThe Essential Role of GATA6 in the Activation of Estrogen Synthesis in Endometriosis
Bernardi, L. A., Dyson, M. T., Tokunaga, H., Sison, C., Oral, M., Robins, J. C., & Bulun, S. E. (2019) · Reproductive Sciences · doi:10.1177/1933719118756751 · Cited by 40
Self-citationIntegrative analysis reveals regulatory programs in endometriosis
Yang, H., Kang, K., Cheng, C., Mamillapalli, R., & Taylor, H. S. (2015) · Reproductive Sciences · doi:10.1177/1933719115592709 · Cited by 39 · cited 1×
“eutopic endometrial stromal cells (Smuc et al., 2007; Xue et al., 2007a; Yang et al., 2015).”
Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis
Cho, Y. J., Lee, J. E., Park, M. J., O’Malley, B. W., & Han, S. J. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0700 · Cited by 37 · cited 1×
“Moreover, the SRC-1 inhibitor bufalin, which leads to ESR2 protein degradation, induces apoptosis in endometriotic epithelial cells and inhibits proliferation of stromal cells (Cho et al., 2018).”
BackgroundDyson, M. T., Kakinuma, T., Pavone, M. E., Monsivais, D., Navarro, A., Malpani, S. S., Ono, M., & Bulun, S. E. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.06.046 · Cited by 37 · cited 2×
“Differential binding activity of DNMT3B to NR5A1 and ESR1 promoters in endometriotic versus normal endometrial stromal cells suggests that this enzyme might play a role in abnormal gene expression in endometriosis (Dyson et al., 2015).”
BackgroundSelf-citationMei, L., Bao, J., Tang, L., Zhang, C., Wang, H., Sun, L., Ma, G., Huang, L., Yang, J., Zhang, L., et al. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.012 · Cited by 36
Selective progesterone receptor modulators
Whitaker, L. H. R., Williams, A. R. W., & Critchley, H. O. D. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000082 · Cited by 35
Huniadi, C. A., Pop, O. L., Antal, T. A., & Stamatian, F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.03.022 · Cited by 35 · cited 1×
“UPA decreases lesion size, attenuates cell proliferation, and induces apoptosis in murine endometriosis models (Huniadi et al., 2013; Liang et al., 2018).”
BackgroundExpression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids
Yin, H., Lo, J. H., Kim, J.-Y., Marsh, E. E., Kim, J. J., Ghosh, A. K., Bulun, S., & Chakravarti, D. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1305 · Cited by 31 · cited 1×
“There are 48 members of the NR superfamily in humans (Yin et al., 2013).”
BackgroundSelf-citationAltered retinoid signaling compromises decidualization in human endometriotic stromal cells
Pavone, M. E., Malpani, S., Dyson, M., & Bulun, S. E. (2017) · Reproduction · doi:10.1530/rep-16-0592 · Cited by 30
Self-citationRANKL/RANK pathway and its inhibitor RANK-Fc in uterine leiomyoma growth
Ikhena, D. E., Liu, S., Kujawa, S., Esencan, E., Coon, J. S., Robins, J., Bulun, S. E., & Yin, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01585 · Cited by 26
Self-citationJunior, M. F. T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3263 · Cited by 25
Yang, S. (2001) · Molecular Endocrinology · doi:10.1210/me.15.12.2093 · Cited by 24
Li, T., He, H., Liu, R., Wang, S. X., & Pu, D.-M. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.04.001 · Cited by 23
Pabalan, N., Salvador, A., Jarjanazi, H., Christofolini, D. M., Barbosa, C. P., & Bianco, B. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3308-3 · Cited by 17 · cited 1×
“A meta-analysis comparing 12 studies concluded that the link between a PGR variant and endometriosis risk was only observed in European subjects (Pabalan et al., 2014).”
MethodA current view of the role of epigenetic changes in the aetiopathogenesis of endometriosis
Kokcu, A. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2015.1036403 · Cited by 13
Retinoic acid regulates endometriotic stromal cell growth through upregulation of Beclin1
Lu, H., Li, S., & Wu, Q. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4549-8 · Cited by 13
Associations between estrogen receptor-beta polymorphisms and endometriosis risk: a meta-analysis
Guo, R., Zheng, N., Ding, S., Zheng, Y., & Feng, L. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0184-x · Cited by 10
Attar, E., Tokunaga, H., İmir, G., Yılmaz, M. B., Redwine, D. B., Putman, M., Gürateş, B., Attar, R., Yaegashi, N., Hales, D. B., et al. (2009) · Molecular Endocrinology · doi:10.1210/mend.23.1.9997 · Cited by 9
Self-citationAdult Stem Cells in the Human Endometrium
Gargett, C. E., Cervelló, I., Hubbard, S. A., & Simón, C. (2009) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092910.015 · Cited by 3
Retinoid Metabolism in Endometriosis
Çakıroğlu, Y., Confino, R., & Pavone, M. E. (2017) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/jeppd.5000309 · Cited by 2
Burney, R. O., Talbi, S., Hamilton, A. E., NEZHAT, C. R., Lessey, B. A., & Giudice, L. C. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.07.725
Afshar, Y., Hastings, J. M., Roqueiro, D., Jeong, J., Giudice, L. C., & Fazleabas, A. T. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.782
The Evolution of Progesterone Receptor Ligands
Madauss, K. P., Stewart, E. L., & Williams, S. P. (2007) · ChemInform · doi:10.1002/chin.200731237
Selective Promoter Usage of the Human Estrogen Receptor- Gene and Its Regulation by Estrogen
Donaghue, C. (1999) · Molecular Endocrinology · doi:10.1210/me.13.11.1934
Kurihara, I., Lee, D.-K., Petit, F. G., Jeong, J., Lee, K., Lydon, J. P., DeMayo, F. J., Tsai, M.-J., & Tsai, S. Y. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030149
Santamaria, X., Cabanillas, S., Arbona, C., & Simon, C. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.07.278
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
“In terms of alterations in ERs activity, an overexpression of ERβ and a downregulation of ERα [39, 40] have been observed in endometriosis.”
BackgroundEndometriosis-Associated Macrophages: Origin, Phenotype, and Function
Hogg, C., Horne, A. W., & Greaves, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00007 · Cited by 238
“Estrogen signaling modulates a large number of down-stream disease processes within endometriosis lesions, which are reviewed in Yilmaz and Bulun (30), Liang et al. (31), and Rizner (32).”
BackgroundRegulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis
García-Gómez, E., Vázquez-Martínez, E. R., Reyes-Mayoral, C., Cruz-Orozco, O. P., Camacho-Arroyo, I., & Cerbón, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00935 · Cited by 195
“In contrast, both progesterone receptor isoforms PR-A and PR-B (PRG) show a decreased expression; in particular, PR-B undergoes a drastic downregulation (mRNA and protein levels), which is mainly due to hypermethylation of the PR-B promoter (25), therefore affecting downstream hormone target genes (26).”
BackgroundDonnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Metadata
- Authors
- Yilmaz, B. D., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Bulun, Serdar E
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-27
- Volume
- 25
- Issue
- 4
- Pages
- 473-485
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- PMC
- PMC6601390
- OpenAlex
- W2915590567
- Cited by
- 243
- References
- 191
- Citations by year
- 2026: 26 · 2025: 27 · 2024: 50 · 2023: 42 · 2022: 30 · 2021: 33 · 2020: 27 · 2019: 7
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R37-HD38691)
- Vehbi Koc Foundation
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- endometriosis, nuclear receptors, estrogen receptor, ESR1, ESR2, progesterone receptor, steroidogenic factor 1, NR2F2, retinoids, estrogen synthesis, progesterone resistance, endometrial differentiation, epigenetic abnormalities, endometriotic stromal cells, stem cell properties
- MeSH terms
- Animals, Endometriosis, Estrogens, Female, Hormone Antagonists, Hormones, Humans, Ligands, Progesterone, Signal Transduction, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.